Atelvia
Active substance: RISEDRONATE SODIUM HEMIPENTAHYDRATE, RISEDRONATE SODIUM MONOHYDRATE
TABLET, DELAYED RELEASE · RISEDRONATE SODIUM HEMIPENTAHYDRATE 30.1 mg/1, RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1
United StatesActive
Marketing holder: Allergan, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- RISEDRONATE SODIUM HEMIPENTAHYDRATE · 30.1 mg/1
- RISEDRONATE SODIUM MONOHYDRATE · 4.9 mg/1
Registration
- Registration number
- 0430-0979
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0430-0979 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0430-0979 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0430-0979 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0430-0979 · Verified 2026-10-09 · open in source